CS logo
small CS logo
Airlangga University Hospital

Surabaya, East Java, Indonesia
Rumah sakit universitas di Surabaya, Jawa Timur

About Airlangga University Hospital


"Rumah Sakit Universitas Airlangga merupakan RS di Surabaya Timur dengan akreditasi B"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Airlangga University Hospital


During the past decade, Airlangga University Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Airlangga University Hospital" #1 collaborator was "Airlangga University" with 1 trials as a collaborator, "Biotis Pharmaceuticals, Indonesia" with 1 trials as a collaborator, "Indonesia-MoH" with 1 trials as a collaborator, "RSIA Kendangsaru MERR Surabaya" with 1 trials as a collaborator and "Universitas Airlangga" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

Clinical Trials Conditions at Airlangga University Hospital


According to Clinical.Site data, the most researched conditions in "Airlangga University Hospital" are "COVID-19 Pandemic" (1 trials), "COVID-19 Vaccines" (1 trials) and "Jaundice, Neonatal" (1 trials). Many other conditions were trialed in "Airlangga University Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Airlangga University Hospital


Most popular intervention types in "Airlangga University Hospital" are "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "CoronaVac Biofarma COVID-19 Vaccine" (1 trials), "Picterus Jaundice Pro" (1 trials) and "Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Airlangga University Hospital


The vast majority of trials in "Airlangga University Hospital" are 2 trials for "All" genders.

Clinical Trials Status at Airlangga University Hospital


Currently, there are NaN active trials in "Airlangga University Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Airlangga University Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Airlangga University Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".